A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokers

Journal of Clinical Psychiatry

Volumn 75, Issue 4, 2014, Pages 336-343

  Winhusen, Theresa M ^a   Brigham, Gregory S ^a,b   Kropp, Frankie ^a   Lindblad, Robert ^c   Gardin II, John G ^e   Penn, Pat ^f   Hodgkins, Candace ^g   Kelly, Thomas M ^h   Douaihy, Antoine ^h   McCann, Michael ⁱ   Love, Lee D ^k   DeGravelles, Eliot ^l   Bachrach, Ken ^j   Sonne, Susan C ^m   Hiott, Bob ⁿ   Haynes, Louise ^o   Sharma, Gaurav ^c   Lewis, Daniel F ^a   Van Veldhuisen, Paul ^c   Theobald, Jeff ^a   Ghitza, Udi ^d   more..

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Maryhaven   (United States)

^c EMMES CORPORATION   (United States)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^e Mercy Medical Center   (United States)

^f LSVT Global   (United States)

^g Gateway Community Services Inc   (United States)

^h Addiction Medicine Services   (United States)

ⁱ Matrix Institute on Addictions   (United States)

^j Tarzana Treatment Centers   (United States)

^k Gibson Recovery   (United States)

^l Nexen Petroleum USA   (United States)

^m Dorchester Alcohol and Drug Commission   (United States)

ⁿ Behavioral Health Services of Pickens County   (United States)

^o Southern Consortium Node   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE;

ABDOMINAL PAIN; ADULT; ANGINA PECTORIS; ANXIETY DISORDER; APPENDICITIS; ARTICLE; ASTHMA; BLURRED VISION; CLINICAL EFFECTIVENESS; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEHYDRATION; DEPRESSION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EXOSTOSIS; FEMALE; FOLLOW UP; HEADACHE; HEART INFARCTION; HEMATOMA; HUMAN; INHALER; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTCOME ASSESSMENT; PANCREATITIS; PANIC; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; PYELONEPHRITIS; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SINUSITIS; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SUBSTANCE ABUSE; SUICIDAL IDEATION; THORAX PAIN; THROAT IRRITATION; TIBIA FRACTURE; TOBACCO DEPENDENCE; TREATMENT DURATION; XEROSTOMIA;

ADULT; AMPHETAMINE-RELATED DISORDERS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; COCAINE-RELATED DISORDERS; COUNSELING; FEMALE; HUMANS; MALE; SMOKING; SMOKING CESSATION; SUBSTANCE-RELATED DISORDERS; TOBACCO USE CESSATION PRODUCTS; TREATMENT OUTCOME;

EID: 84899739109     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/jcp.13m08449     Document Type: Article

References (35)

1. Centers for Disease Control and Prevention (CDC). Smoking attributable mortality, years of potential life lost, and productivity losses United States, 2000-2004. MMWRMorbMortal Wkly Rep. 2008;57(45):1226-1228.
2. Schroeder SA. A 51 year old woman with bipolar disorder who wants to quit smoking. JAMA. 2009;301(5):522-531.
3. Hurt RD, Offord KP, Croghan IT, et al. Mortality following inpatient addictions treatment: Role of tobacco use in a community based cohort. JAMA. 1996;275(14):1097-1103.
4. Ziedonis DM, Guydish J, Williams J, et al. Barriers and solutions to addressing tobacco dependence in addiction treatment programs. Alcohol Res Health. 2006;29(3):228-235.
5. Prochaska JJ. Failure to treat tobacco use in mental health and addiction treatment settings: A form of harm reduction? Drug Alcohol Depend. 2010;110(3):177-182.
6. Prochaska JJ, Delucchi K, Hall SM. A meta analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. I Consult Clin Psychol. 2004;72(6):1144-1156.
7. Budney AJ, Higgins ST, Hughes JR, et al. Nicotine and caffeine use in cocaine dependent individuals. I Subst Abuse. 1993;5(2): 117-130.
8. Sees KL, Clark HW When to begin smoking cessation in substance abusers. J Subst Abuse Treat. 1993;10(2):189-195.
9. Gorelick DA, Simmons MS, Carriero N, et al. Characteristics of smoked drug use among cocaine smokers. Am I Addict. 1997;6(3):237-245.
10. Grant KM, Kelley SS, Agrawal S, et al. Methamphetamine use in rural Midwesterners. Am JAddict. 2007;16(2):79
11. Weinberger AH, Sofuoglu M. The impact of cigarette smoking on stimulant addiction. Am JDrugAlcohol Abuse. 2009;35(1):12
12. Roll JM, Higgins ST, Tidey J. Cocaine use can increase cigarette smoking: Evidence from laboratory and naturalistic settings. Exp Clin PsychopharmacoL 1997;5(3):263-268.
13. Nemeth Coslett R, Henningfield J, Katz J, et al. Effect of cocaine on rate of cigarette smoking. Pharmacol Biochem Behav. 1986;25(1):303.
14. Roll JM, Higgins ST, Budney AJ, et al. A comparison of cocaine dependent cigarette smokers and non smokers on demographic, drug use and other characteristics. Drug Alcohol Depend. 1996;40(3): 195-201.
15. Reid MS, Mickalian JD, Delucchi KL, et al. A nicotine antagonist, mecamylamine, reduces cue induced cocaine craving in cocaine dependent subjects. Neuropsychopharmacology. 1999;20(3):297-307.
16. Reid MS, Mickalian JD, Delucchi KL, et al. An acute dose of nicotine enhances cue induced cocaine craving. Drug Alcohol Depend. 1998;49(2):95-104.
17. Shoptaw S, Rotheram Fuller E, Yang X, et al. Smoking cessation in methadone maintenance. Addiction. 2002;97( 10): 1317-1328, discussion 1325.
18. Reid MS, Fallon B, Sonne S, et al. Smoking cessation treatment in community based substance abuse rehabilitation programs. I Subst Abuse Treat. 2008;35(1):68
19. Ebbert JO, Croghan IT, Sood A, et al. Varenicline and bupropion sustained release combination therapy for smoking cessation. Nicotine Tob Res. 2009;11(3):234-239.
20. Fiore MC, Jaen CR, Baker TB, et al; Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update: A US Public Health Service report. Am JPrev Med. 2008;35(2):158-176.
21. Winhusen T, Stitzer M, Woody G, et al. Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant dependent individuals. Contemp Clin Trials. 2012;33(1):197-205.
22. Croghan IT, Trautman JA, Winhusen T, et al. Tobacco dependence counseling in a randomized multisite clinical trial. Contemp Clin Trials. 2012;33(4):576-582.
23. Sobell LC, Sobell MB. Timeline follow back a technique for assessing self reported alcohol consumption. In: Allen J, ed. Measuring Alcohol Consumption. Totowa, NJ: Humana Press; 1992:41
24. Fals Stewart W, O?Farrell TJ, Freitas TT, et al. The timeline followback reports of psychoactive substance use by drug abusing patients: Psychometric properties. I Consult Clin PsychoL 2000;68(1):134-144.
25. Hurt lID, Krook JE, Croghan IT, et al. Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking. JClin OncoL 2003;21(5):914-920.
26. Nakagawa S. A farewell to Bonferroni: The problems of low statistical power and publication bias. Behav Ecol. 2004;15(6):1044-1045.
27. Bobo JK, Mcllvain HE, Lando HA, et al. Effect of smoking cessation counseling on recovery from alcoholism: Findings from a randomized community intervention trial. Addiction. 1998;93(6):877-887.
28. Croghan IT, Hurt RD, Dakhil SR, et al. Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention. Mayo Clin Proc. 2007;82(2):186-195.
29. Gonzales D, Rennard SI, Nides M, et al; Varenicline Phase 3 Study Group. Varenicline, an alpha4beta2 nicotinic acetyicholine receptor partial agonist, vs sustained release bupropion and placebo for smoking cessation: A randomized controlled trial. JAMA. 2006;296(1):47
30. Jorenby DE, Hays JT, Rigotti NA, et al; Varenicline Phase 3 Study Group. Efficacy of varenicline, an alpha4beta2 nicotinic acetyicholine receptor partial agonist, vs placebo or sustained release bupropion for smoking cessation: A randomized controlled trial. JAMA. 2006;296(1):56
31. Kalman D, Herz L, Monti P, et al. Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: Results from a randomized, double blind, placebo controlled study. DrugAlcohol Depend. 2011;118(2-3):111-118.
32. Grant KM, Kelley SS, Smith LM, et al. Bupropion and nicotine patch as smoking cessation aids in alcoholics. AlcohoL 2007;41(5):381-391.
33. Hurt PD, Sachs DP, Glover ED, et al. A comparison of sustained release bupropion and placebo for smoking cessation. NEngIJ Med. 1997;337(17):1195-1202.
34. Winhusen T, Winstanley EL, Somoza E, et al. The potential impact of recruitment method on sample characteristics and treatment outcomes in a psychosocial trial for women with co occurring substance use disorder and PTSD. DrugAlcohol Depend. 2012;120(1-3):225-228.
35. Baca CT, Yahne CE. Smoking cessation during substance abuse treatment: What you need to know. I Subst Abuse Treat. 2009;36(2):205-219.